Fabtech Technologies Cleanrooms Ltd

Resolution details

• Special resolution to issue convertible warrants on a preferential basis to promoters and promoter group.
• Warrant issuance exempted from related party transaction per SEBI listing regulations.
• Resolution passed with 99.41% in favour and 0.59% against.

EGM Resolution Details

• Resolution: Special; issue of convertible warrants on a preferential basis to promoters and promoter group.
• Nature: Preferential allotment of convertible warrants.
• Key terms: number, price, and conversion terms not disclosed.
• Intended allottees: Promoters and promoter group.
• Interest: promoters/promoter group are intended allottees.
• Approvals: In-principle BSE approvals filed for the preferential issue.
• Questions: No shareholder queries raised at the EGM.
• Voting outcome: Results pending; to be announced within 2 working days.
• Proceeds: Use of funds not disclosed.
• Governance: No board/management changes reported.
• Certifications: Pricing and ICDR compliance certificates available for inspection.
• Quorum: Eight members present via VC/OAVM.
• Conclusion: Meeting concluded at 12:37 PM IST.

July 2026 orders and order book

• July 2026 consolidated orders ₹152.30 cr, led by Pharma ₹88.42 cr, Renewable Energy ₹63.00 cr, Others ₹0.88 cr.
• Contributions by vertical: Cleanroom Partitions ₹150.54 cr and HVAC Systems ₹1.76 cr.
• Consolidated order book as at 31 July 2026: ₹490.13 crore.
• Order book by segment: Renewable Energy ₹224.73 cr, Pharma ₹229.11 cr.
• Data Centres ₹26.03 cr, Semiconductors ₹0.50 cr, Others ₹9.76 cr.
• Active orders under consideration ₹425.65 cr.
• Major opportunities: Pharma ₹204.15 cr, Renewable Energy ₹128.30 cr.
• Healthcare and life sciences order ₹70 cr; Renewable energy order ₹63 cr.

Resolution details and impact

• Purpose: Preferential issue of convertible warrants to promoters/promoter group.
• Type: Special resolution for warrant issue.
• Warrants: up to 3,80,711; price INR 394 per warrant.
• Conversion: 1 warrant converts to 1 equity share.
• Exercise period: 18 months from allotment.
• Total target raise: INR 15,00,00,134.
• Promoter allottees: Amer Aasif Khan; Hemant Mohan Anavkar; Manisha Hemant Anavkar; Aarif Ahsan Khan.
• Warrant subscription price: INR 98.50 per warrant.
• Warrant exercise price: INR 295.50 per warrant.
• Floor price: INR 393.60; warrants priced at 394 above floor.
• Pre-issue promoter holding: 68.49%; post-issue: 69.43%.
• Public shareholding: pre 31.51%; post 30.57%.
• Use of proceeds: Working capital INR 11,30,00,134; general corporate INR 3,70,00,000.
• Monitoring: No monitoring agency due to warrant issue below INR 100 crore.
• Change in control: No change in control; promoters remain.
• Listing: Shares to be listed; pari-passu with existing.
• Voting rights: Warrants have no voting rights until conversion.
• Board approval: July 20, 2026; EGM date Aug 17, 2026.
• Relevant date: July 17, 2026.
• Subject to regulatory approvals; transfer of rights governed by ICDR regulations.
• Promoter group eligible to vote; related party restrictions do not apply.

Warrants issuance details

• Fully convertible warrants issued on a preferential basis to promoters and promoter group.
• Total warrants: up to 3,80,711 at INR 394 each, aggregating INR 15,00,00,134.
• Warrant subscription price INR 98.50; exercise price INR 295.50 per warrant.
• Exercise period of 18 months; lapse if unexercised, with subscription price forfeited.
• Each warrant converts into one fully paid equity share of INR 10.

Promoter allottees and post-issue holdings

• Proposed allottees are promoters: Amer Aasif Khan; Hemant Mohan Anavkar; Manisha Hemant Anavkar; Aarif Ahsan Khan.
• Post-issue holdings: Amer Aasif Khan 2,29,916 shares (1.81%).
• Hemant Mohan Anavkar post-issue: 10,88,392 shares (8.57%).
• Manisha Hemant Anavkar post-issue: 10,85,995 shares (8.55%).
• Aarif Ahsan Khan post-issue: 13,04,417 shares (10.27%).

Listing and approvals

• Listing on BSE subject to members' approval and regulatory clearances.
• EGM scheduled Aug 17, 2026; warrants issuance requires member approval.

Meeting Details

• Board meeting scheduled on Monday, July 20, 2026; time and venue not disclosed.

Key Agenda Items

• Approve fundraising via preferential issue of equity shares and/or convertible warrants, subject to requisite approvals.
• Approve appointment of Ms. Jai Vaidya as Company Secretary Compliance Officer (KMP).

Other Notes

• Trading window remains closed and reopens 48 hours after board meeting outcome.

June 2026 orders

• Consolidated orders in June 2026 totaled ₹33.79 crore, led by Pharma ₹20.36 crore.
• Vertical contributions: HVAC Systems ₹17.81 crore; Cleanroom Partitions ₹15.98 crore.
• As of 30 June 2026, consolidated order book stood at ₹362.41 crore.
• Order book by segment: Renewable Energy ₹177.63 cr; Pharma ₹147.40 cr; Data Centres ₹26.74 cr.
• Semiconductors ₹0.50 cr; Others ₹10.14 cr.

Active opportunities

• Orders under active consideration total ₹514.78 crore.
• Major opportunities: Pharma ₹229.01 cr; Renewable Energy ₹269.00 cr; Data Centres ₹12.00 cr; Others ₹4.77 cr.

Strategic diversification

• Diversification across Renewable Energy, Pharmaceuticals, Data Centres and other high-growth sectors continues.

June 2026 orders

• June 2026 consolidated orders: ₹33.79 crore, led by Pharma ₹20.36 crore.
• Others contributed ₹8.98 crore; Renewable Energy ₹4.45 crore.

Order book status

• Order book as of 30 June 2026: ₹362.41 crore.
• Composition: Renewable Energy ₹177.63 crore; Pharma ₹147.40 crore.

Active opportunities

• Active opportunities total ₹65.22 crore.
• Major opportunities: Pharma ₹25.45 crore, Renewable Energy ₹23.00 crore, Data Centres ₹12.00 crore, Others ₹4.77 crore.

Growth sectors & diversification

• Diversification across Renewable Energy, Pharmaceuticals, Data Centers, Semiconductors, Nutraceuticals and other manufacturing industries.

Reg 74(5) compliance status

• Certificate from the RTA confirms compliance under Reg 74(5) for quarter ended June 30, 2026.